Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
232
NCT01211470
Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2010
Completion: Mar 31, 2012
NCT01312935
Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Start: Apr 30, 2011
Completion: Aug 31, 2012